Results: 37
Erratum to: Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma.
- Published in:
- 2023
- Publication type:
- Correction Notice
Treatment discontinuation in chronic myeloid leukemia: When, how, and why?
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1670, doi. 10.1002/ajh.27100
- By:
- Publication type:
- Article
Germline DDX41 mutant predisposition syndromes: Slow driver states to hematological malignancies.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1673, doi. 10.1002/ajh.27091
- By:
- Publication type:
- Article
Age‐adjusted D‐dimer, clinical pre‐test probability‐adjusted D‐dimer, and whole leg ultrasound in ruling out suspected proximal and calf deep venous thrombosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1772, doi. 10.1002/ajh.27077
- By:
- Publication type:
- Article
Long‐term follow‐up of tandem CD19/CD22 CAR T‐Cells in r/r B‐ALL patients with high‐risk features.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E338, doi. 10.1002/ajh.27076
- By:
- Publication type:
- Article
2024 Update: Advances in the risk stratification and management of large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1791, doi. 10.1002/ajh.27075
- By:
- Publication type:
- Article
Males with sickle cell disease have higher risks of cerebrovascular disease, increased inflammation, and a reduced response to hydroxyurea.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E341, doi. 10.1002/ajh.27074
- By:
- Publication type:
- Article
Risk of progression in chronic phase‐chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR‐PRO study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1762, doi. 10.1002/ajh.27073
- By:
- Publication type:
- Article
Immunomodulatory cytokines and clonal dynamics in low‐risk myelodysplastic syndromes patients treated with luspatercept.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E345, doi. 10.1002/ajh.27072
- By:
- Publication type:
- Article
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1780, doi. 10.1002/ajh.27070
- By:
- Publication type:
- Article
Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1751, doi. 10.1002/ajh.27069
- By:
- Publication type:
- Article
Targeted dosing of anti‐thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single‐arm, phase 2 trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1732, doi. 10.1002/ajh.27068
- By:
- Publication type:
- Article
Severe cutaneous necrosis in antiphospholipid syndrome.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E328, doi. 10.1002/ajh.27067
- By:
- Publication type:
- Article
Prognostic impact of second primary malignancies in multiple myeloma: An ASCO CancerLinQ discovery analysis of the modern era.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E325, doi. 10.1002/ajh.27066
- By:
- Publication type:
- Article
Ongoing symptoms following complete surgical excision in unicentric Castleman disease.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E334, doi. 10.1002/ajh.27065
- By:
- Publication type:
- Article
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1742, doi. 10.1002/ajh.27064
- By:
- Publication type:
- Article
Teclistamab in patients with multiple myeloma and impaired renal function.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E322, doi. 10.1002/ajh.27063
- By:
- Publication type:
- Article
Autoimmunity in sickle cell disease: Analysis of a large cohort of adult patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E315, doi. 10.1002/ajh.27061
- By:
- Publication type:
- Article
Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E318, doi. 10.1002/ajh.27060
- By:
- Publication type:
- Article
The complex relationship between iron status and anemia in pregnant and postpartum women in India: Analysis of two Indian study cohorts of uncomplicated pregnancies.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1721, doi. 10.1002/ajh.27059
- By:
- Publication type:
- Article
Outpatient CD28‐costimulated CAR T‐cells for B‐cell malignancies with CNS involvement.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E301, doi. 10.1002/ajh.27051
- By:
- Publication type:
- Article
Megakaryocyte morphology with GATA2 germline mutation.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1806, doi. 10.1002/ajh.27057
- By:
- Publication type:
- Article
Diagnosis of breast implant associated anaplastic large cell lymphoma by analysis of cytokines in peri‐implant seromas.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E312, doi. 10.1002/ajh.27055
- By:
- Publication type:
- Article
Phase II study of cladribine, idarubicin, and ara‐C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1711, doi. 10.1002/ajh.27054
- By:
- Publication type:
- Article
Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E305, doi. 10.1002/ajh.27053
- By:
- Publication type:
- Article
Re‐assessing the effect of fetal hemoglobin on stroke in the Cooperative Study of Sickle Cell Disease.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E309, doi. 10.1002/ajh.27052
- By:
- Publication type:
- Article
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1699, doi. 10.1002/ajh.27056
- By:
- Publication type:
- Article
Daratumumab monotherapy for relapsed POEMS syndrome.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E291, doi. 10.1002/ajh.27050
- By:
- Publication type:
- Article
Dramatic efficacy of cannabidiol on refractory chronic pain in an adolescent with sickle cell disease.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E295, doi. 10.1002/ajh.27049
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitor treatment in essential thrombocythemia: Impact on hemoglobin/hematocrit levels and outcomes among 11 consecutive patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E298, doi. 10.1002/ajh.27048
- By:
- Publication type:
- Article
Erythropoietin‐secreting metanephric adenoma presenting as erythrocytosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1808, doi. 10.1002/ajh.27047
- By:
- Publication type:
- Article
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine—A prospective cohort study by the AGMT
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1685, doi. 10.1002/ajh.27046
- By:
- Publication type:
- Article
Pregnancy‐related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1677, doi. 10.1002/ajh.27045
- By:
- Publication type:
- Article
Kiss of death between CAR‐T cells and KMT2a::AFF1 B lymphoblasts in the central nervous system.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1816, doi. 10.1002/ajh.27000
- By:
- Publication type:
- Article
Is this really thalassemia?
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1814, doi. 10.1002/ajh.26913
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1667, doi. 10.1002/ajh.26614
- Publication type:
- Article
Withdrawal: "Primary prevention of sickle cell disease using preimplantation genetic testing and in vitro fertilization is cost‐effective." Christina N. Cordeiro Mitchell, Apoorva Pradhan, Bhuchitra Singh, Rakhi P. Naik, Valerie L. Baker, Sophie M. Lanzkron, Mindy S. Christianson, Lydia H. Pecker
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1819, doi. 10.1002/ajh.25974
- Publication type:
- Article